These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7594427

  • 1. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
    Black MJ, Bertram JF, Campbell JH, Campbell GR.
    J Hypertens; 1995 Jun; 13(6):683-92. PubMed ID: 7594427
    [Abstract] [Full Text] [Related]

  • 2. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF.
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [Abstract] [Full Text] [Related]

  • 3. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ, Campbell JH, Campbell GR.
    Am J Cardiol; 1993 Jun 24; 71(17):17E-21E. PubMed ID: 8328362
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct 24; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 5. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug 24; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 6. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF, Devlin AM, Lee WK, Anderson NH, Bohr DF, Reid JL.
    Hypertension; 1996 Mar 24; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [Abstract] [Full Text] [Related]

  • 7. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ, Kanellakis P, Bobik A.
    J Hypertens; 1997 Sep 24; 15(9):945-54. PubMed ID: 9321741
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
    Harrap SB, Mitchell GA, Casley DJ, Mirakian C, Doyle AE.
    Hypertension; 1993 Jan 24; 21(1):50-5. PubMed ID: 8418023
    [Abstract] [Full Text] [Related]

  • 9. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N, Head GA.
    J Hypertens; 1993 May 24; 11(5):523-33. PubMed ID: 8390524
    [Abstract] [Full Text] [Related]

  • 10. Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats.
    Chillon JM, Baumbach GL.
    Hypertension; 1999 Mar 24; 33(3):856-61. PubMed ID: 10082499
    [Abstract] [Full Text] [Related]

  • 11. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF.
    Hypertension; 1990 Dec 24; 16(6):603-14. PubMed ID: 2246027
    [Abstract] [Full Text] [Related]

  • 12. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
    Campbell DJ, Duncan AM, Kladis A, Harrap SB.
    J Cardiovasc Pharmacol; 1995 Sep 24; 26(3):426-36. PubMed ID: 8583785
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ, Blaschak CM, Chinoy MR, Jackson EK.
    Mol Cell Biochem; 2000 Sep 24; 212(1-2):121-9. PubMed ID: 11108143
    [Abstract] [Full Text] [Related]

  • 14. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
    Touyz RM, Endemann D, He G, Li JS, Schiffrin EL.
    Hypertension; 1999 Jan 24; 33(1 Pt 2):366-72. PubMed ID: 9931131
    [Abstract] [Full Text] [Related]

  • 15. Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
    Head GA, Minami N.
    Am J Med; 1992 Apr 27; 92(4B):54S-59S. PubMed ID: 1533747
    [Abstract] [Full Text] [Related]

  • 16. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linz W, Schölkens BA, Wiemer G, Unger T.
    Hypertension; 1993 Nov 27; 22(5):682-7. PubMed ID: 8225528
    [Abstract] [Full Text] [Related]

  • 17. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
    Thomas CJ, Head GA, Woods RL.
    Hypertension; 1998 Sep 27; 32(3):548-55. PubMed ID: 9740624
    [Abstract] [Full Text] [Related]

  • 18. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T.
    J Hypertens; 1993 Dec 27; 11(12):1347-55. PubMed ID: 8133017
    [Abstract] [Full Text] [Related]

  • 19. Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
    Black MJ, Bertram JF, Johnston CI.
    J Hypertens; 2001 Apr 27; 19(4):785-94. PubMed ID: 11330882
    [Abstract] [Full Text] [Related]

  • 20. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS, Sharifi AM, Schiffrin EL.
    J Cardiovasc Pharmacol; 1997 Jul 27; 30(1):75-83. PubMed ID: 9268224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.